Aurora Cannabis Sees Product Approved For Irish Market

Aurora Cannabis (TSX: ACB) (NYSE: ACB) announced this morning that the firm has expanded its international market exposure to that of Ireland. The firm recently saw one of its oil products approved for import to the European country.

Ireland recently implemented a new Medical Cannabis Access Programme (MCAP), which is slated to run for five years following legislation that was signed into law in June 2019 by the Minister of Health. The approval for medical cannabis is currently limited to a narrow set of medical conditions which include spasticity associated with multiple sclerosis, nausea associated with chemotherapy, and severe epilepsy.

Aurora’s High CBD Oil Drops product is the second product to be approved for importation, prescription, and supply under the new legislation, following Tilray’s approval this past summer. Tilray Inc (NASDAQ: TLRY) shipped an undisclosed amount of cannabis oil to Ireland for use in the MCAP program back in early July, following the initial approval of the program by the health minister.

Aurora did not disclose when the first shipment of CBD oil will be made to the European nation, or what quantities are expected to be exported.

Aurora Cannabis closed Friday’s session at $2.50 on the New York Stock Exchange.


Information for this briefing was found via Sedar and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Aurora Cannabis To Commence Trading On Nasdaq

Aurora Cannabis Inc. (TSX: ACB) (NASDAQ: ACB), last night reported that the company has completed...

Tuesday, May 25, 2021, 07:18:04 AM

Aurora Cannabis Replaces CFO, Conducts Reverse Split

Aurora Cannabis (TSX: ACB) is reporting this morning that it is replacing its chief financial...

Tuesday, February 20, 2024, 08:08:27 AM

Stifel Downgrades Aurora Cannabis Price Target To $3.60 Based On Liquidation Analysis

This morning, Stifel downgraded their 12-month price target on Aurora Cannabis (TSX: ACB) (NYSE: ACB)...

Wednesday, October 28, 2020, 10:59:00 AM

Saturated: The Canadian Cannabis Production Landscape

The Canadian cannabis landscape, in a word, is saturated. Despite the best intentions of sector...

Sunday, November 3, 2019, 09:00:16 AM

Aurora Cannabis Posts Annual Gross Revenues of $271 Million

Aurora Cannabis (TSX: ACB) (NYSE: ACB) posted its fourth quarter financials after the bell today,...

Wednesday, September 11, 2019, 05:58:51 PM